UNLIMITED TURBO LONG - AMGEN | Market Closed - Börse Stuttgart 01:15:32 01/06/2024 am IST | ||
| 13.88 EUR | +2.13% |
|
| 1 month | +22.61% | ||
| 3 months | +21.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 13.88 | +2.13% |
| 30/24/30 | 13.59 | +3.27% |
| 29/24/29 | 13.16 | -2.01% |
| 28/24/28 | 13.43 | -5.62% |
| 27/24/27 | 14.23 | +1.64% |
Delayed Quote Börse Stuttgart
Last update May 01, 2024 at 01:15 am IST
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PP97G4 |
| ISIN | DE000PP97G44 |
| Date issued | 29/06/2018 |
| Strike | 155.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.08 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.24 € |
|---|---|
| Lowest since issue | 2.36 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
